Disc Medicine to Participate in Upcoming Investor Conferences
31 8월 2023 - 5:15AM
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage
biopharmaceutical company focused on the discovery, development,
and commercialization of novel treatments for patients suffering
from serious hematologic diseases, announced today that company
management will participate in fireside chats at four upcoming
investor conferences:
- The 2023 Wells Fargo Healthcare Conference on Friday, September
8th at 8:45 am ET.
- The Morgan Stanley 21st Annual Global Healthcare Conference on
Wednesday, September 13th at 8:50 am ET.
- The H.C. Wainwright 25th Annual Global Investment Conference on
Wednesday, September 13th at 11:00 am ET.
- The 2023 Cantor Global Healthcare Conference on Wednesday,
September 27th at 2:25 pm ET.
A live webcast of the fireside chats will be available through
the investor relations section of the Company's website at
ir.discmedicine.com and an archived replay will be available after
the event.
About Disc
Disc Medicine (NASDAQ:IRON) is a clinical-stage
biopharmaceutical company committed to discovering, developing, and
commercializing novel treatments for patients who suffer from
serious hematologic diseases. We are building a portfolio of
innovative, potentially first-in-class therapeutic candidates that
aim to address a wide spectrum of hematologic diseases by targeting
fundamental biological pathways of red blood cell biology,
specifically heme biosynthesis and iron homeostasis. For more
information, please visit www.discmedicine.com.
Media Contact
Peg RusconiVerge Scientific
Communicationsprusconi@vergescientific.com
Investor Relations Contact
Christina TartagliaStern Investor
Relationschristina.tartaglia@sternir.com
Disc Medicine (NASDAQ:IRON)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Disc Medicine (NASDAQ:IRON)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024